{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:37:45Z","timestamp":1761237465203},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2007,8,14]],"date-time":"2007-08-14T00:00:00Z","timestamp":1187049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2007,10,4]]},"DOI":"10.1007\/s00210-007-0180-8","type":"journal-article","created":{"date-parts":[[2007,8,13]],"date-time":"2007-08-13T11:19:25Z","timestamp":1187003965000},"page":"107-115","source":"Crossref","is-referenced-by-count":12,"title":["Urotensin II acutely increases myocardial length and distensibility: potential implications for diastolic function and ventricular remodeling"],"prefix":"10.1007","volume":"376","author":[{"given":"Ana Patr\u00edcia","family":"Fontes-Sousa","sequence":"first","affiliation":[]},{"given":"Carmen","family":"Br\u00e1s-Silva","sequence":"additional","affiliation":[]},{"given":"Ana Lu\u00edsa","family":"Pires","sequence":"additional","affiliation":[]},{"given":"Daniela","family":"Monteiro-Sousa","sequence":"additional","affiliation":[]},{"given":"Adelino F.","family":"Leite-Moreira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,8,14]]},"reference":[{"key":"180_CR1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/45809","volume":"401","author":"RS Ames","year":"1999","unstructured":"Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu WS, Glover GI, Wilson S, McNulty DE, Ellis CE, Elshourbagy NA, Shabon U, Trill JJ, Hay DW, Ohlstein EH, Bergsma DJ, Douglas SA (1999) Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401:282\u2013286","journal-title":"Nature"},{"key":"180_CR2","first-page":"533","volume":"41","author":"HA Bern","year":"1985","unstructured":"Bern HA, Pearson D, Larson BA, Nishioka RS (1985) Neurohormones from fish tails: the caudal neurosecretory system. I. \u201cUrophysiology\u201d and the caudal neurosecretory system of fishes. Recent Prog Horm Res 41:533\u2013552","journal-title":"Recent Prog Horm Res"},{"key":"180_CR3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/sj.bjp.0704448","volume":"135","author":"F Bohm","year":"2002","unstructured":"Bohm F, Pernow J (2002) Urotensin II evokes potent vasoconstriction in humans in vivo. Br J Pharmacol 135:25\u201327","journal-title":"Br J Pharmacol"},{"key":"180_CR4","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/01.CIR.0000155257.33485.6D","volume":"111","author":"A Borbely","year":"2005","unstructured":"Borbely A, van der Velden J, Papp Z, Bronzwaer JG, Edes I, Stienen GJ, Paulus WJ (2005) Cardiomyocyte stiffness in diastolic heart failure. Circulation 111: 774\u2013781","journal-title":"Circulation"},{"key":"180_CR5","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/sj.bjp.0703513","volume":"130","author":"FE Bottrill","year":"2000","unstructured":"Bottrill FE, Douglas SA, Hiley CR, White R (2000) Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries. Br J Pharmacol 130: 1865\u20131870","journal-title":"Br J Pharmacol"},{"key":"180_CR6","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.peptides.2006.06.011","volume":"11","author":"N Bousette","year":"2006","unstructured":"Bousette N, Pottinger J, Ramli W, Ohlstein EH, Dhanak D, Douglas SA, Giaid A (2006) Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart disease. Peptides 11:2919\u20132926","journal-title":"Peptides"},{"key":"180_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1152\/physrev.00017.2002","volume":"83","author":"DL Brutsaert","year":"2003","unstructured":"Brutsaert DL (2003) Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 83:59\u2013115","journal-title":"Physiol Rev"},{"key":"180_CR8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/01.RES.62.2.358","volume":"62","author":"DL Brutsaert","year":"1988","unstructured":"Brutsaert DL, Meulemans AL, Spido KR, Sys SU (1988) Effects of damaging endocardial surface on the mechanical performance of isolated cardiac muscle. Circ Res 62:358\u2013366","journal-title":"Circ Res"},{"key":"180_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0033-0620(96)80004-1","volume":"39","author":"DL Brutsaert","year":"1996","unstructured":"Brutsaert DL, De Keulenaer GW, Fransen P, Mohan P, Kaluza GL, Andries LJ, Rouleau JL, Sys SU (1996) The cardiac endothelium: functional morphology, development, and physiology. Prog Cardiovasc Dis 39:239\u2013262","journal-title":"Prog Cardiovasc Dis"},{"key":"180_CR10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00210-001-0503-0","volume":"365","author":"V Camarda","year":"2002","unstructured":"Camarda V, Rizzi A, Calo G, Gendron G, Perron SI, Kostenis E, Zamboni P, Mascoli F, Regoli D (2002) Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents. Naunyn Schmiedebergs Arch Pharmacol 365:141\u2013149","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"180_CR11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/(SICI)1097-010X(19960601\/15)275:2\/3<226::AID-JEZ14>3.0.CO;2-H","volume":"275","author":"JM Conlon","year":"1996","unstructured":"Conlon JM, Yano K, Waugh D, Hazon N (1996) Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates. J Exp Zool 275:226\u2013238","journal-title":"J Exp Zool"},{"key":"180_CR12","doi-asserted-by":"crossref","first-page":"15803","DOI":"10.1073\/pnas.95.26.15803","volume":"95","author":"Y Coulouarn","year":"1998","unstructured":"Coulouarn Y, Lihrmann I, Jegou S, Anouar Y, Tostivint H, Beauvillain JC, Conlon JM, Bern HA, Vaudry H (1998) Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA 95:15803\u201315808","journal-title":"Proc Natl Acad Sci USA"},{"key":"180_CR13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0014-5793(99)01003-0","volume":"457","author":"Y Coulouarn","year":"1999","unstructured":"Coulouarn Y, Jegou S, Tostivint H, Vaudry H, Lihrmann I (1999) Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett 457:28\u201332","journal-title":"FEBS Lett"},{"key":"180_CR14","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/sj.bjp.0703690","volume":"131","author":"SA Douglas","year":"2000","unstructured":"Douglas SA, Sulpizio AC, Piercy V, Sarau HM, Ames RS, Aiyar NV, Ohlstein EH, Willette RN (2000) Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey. Br J Pharmacol 131:1262\u20131274","journal-title":"Br J Pharmacol"},{"key":"180_CR15","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/S0140-6736(02)08831-1","volume":"359","author":"SA Douglas","year":"2002","unstructured":"Douglas SA, Tayara L, Ohlstein EH, Halawa N, Giaid A (2002) Congestive heart failure and expression of myocardial urotensin II. Lancet 359:1990\u20131997","journal-title":"Lancet"},{"key":"180_CR16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0167-0115(02)00158-1","volume":"110","author":"T Dschietzig","year":"2002","unstructured":"Dschietzig T, Bartsch C, Pregla R, Zurbrugg HR, Armbruster FP, Richter C, Laule M, Romeyke E, Neubert C, Voelter W, Baumann G, Stangl K (2002) Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure. Regul Pept 110:33\u201338","journal-title":"Regul Pept"},{"key":"180_CR17","first-page":"II","volume":"114","author":"AP Fontes-Sousa","year":"2006","unstructured":"Fontes-Sousa AP, Br\u00e1s-Silva C, Pires AP, Monteiro-Sousa D, Leite-Moreira AF (2006). Urotensin-II: a novel neurohumoral modulator of diastolic function. Circulation 114:II\u2013315","journal-title":"Circulation"},{"key":"180_CR18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1085\/jgp.200409177","volume":"125","author":"N Fukuda","year":"2005","unstructured":"Fukuda N, Wu Y, Nair P, Granzier HL (2005) Phosphorylation of titin modulates passive stiffness of cardiac muscle in a titin isoform-dependent manner. J Gen Physiol 125:257\u2013271","journal-title":"J Gen Physiol"},{"key":"180_CR19","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/sj.bjp.0704051","volume":"132","author":"SM Gardiner","year":"2001","unstructured":"Gardiner SM, March JE, Kemp PA, Davenport AP, Bennett T (2001) Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats. Br J Pharmacol 132:1625\u20131629","journal-title":"Br J Pharmacol"},{"key":"180_CR20","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1152\/japplphysiol.00540.2004","volume":"97","author":"H Gong","year":"2004","unstructured":"Gong H, Wang YX, Zhu YZ, Wang WW, Yao T, Zhu YC (2004) Cellular distribution of GPR14 and the positive inotropic role of urotensin II in the myocardium in adult rat. J Appl Physiol 97:2228\u20132235","journal-title":"J Appl Physiol"},{"key":"180_CR21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1139\/y03-004","volume":"81","author":"GS Hassan","year":"2003","unstructured":"Hassan GS, Chouiali F, Saito T, Hu F, Douglas SA, Ao Z, Willette RN, Ohlstein EH, Giais A (2003) Effect of human urotensin-II infusion on hemodynamics and cardiac function. Can J Physiol Pharm 81:125\u2013128","journal-title":"Can J Physiol Pharm"},{"key":"180_CR22","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1161\/01.CIR.99.23.3009","volume":"99","author":"C Heymes","year":"1999","unstructured":"Heymes C, Vanderheyden M, Bronzwaer JG, Shah AM, Paulus WJ (1999) Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation 99:3009\u20133016","journal-title":"Circulation"},{"key":"180_CR23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.peptides.2005.07.012","volume":"27","author":"A Ishihata","year":"2006","unstructured":"Ishihata A, Sakai M, Katano Y (2006) Vascular contractile effect of urotensin II in young and aged rats: influence of aging and contribution of endothelial nitric oxide. Peptides 27:80\u201386","journal-title":"Peptides"},{"key":"180_CR24","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1161\/01.CIR.95.9.2303","volume":"95","author":"N Ito","year":"1997","unstructured":"Ito N, Bartunek J, Spitzer KW, Lorell BH (1997) Effects of the nitric oxide donor sodium nitroprusside on intracellular pH and contraction in hypertrophied myocytes. Circulation 95:2303\u20132311","journal-title":"Circulation"},{"key":"180_CR25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00210-004-0980-z","volume":"370","author":"DG Johns","year":"2004","unstructured":"Johns DG, Ao Z, Naselsky D, Herold CL, Maniscalco K, Sarov-Blat L, Steplewski K, Aiyar N, Douglas SA (2004) Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators. Naunyn Schmiedebergs Arch Pharmacol 370:238\u2013250","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"180_CR26","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/01.RES.0000129254.25507.d6","volume":"94","author":"DA Kass","year":"2004","unstructured":"Kass DA, Bronzwaer JG, Paulus WJ (2004) What mechanisms underlie diastolic dysfunction in heart failure? Circ Res 94:1533\u20131542","journal-title":"Circ Res"},{"key":"180_CR27","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/hrt.2005.062950","volume":"92","author":"AF Leite-Moreira","year":"2006","unstructured":"Leite-Moreira AF (2006) Current perspectives in diastolic dysfunction and diastolic heart failure. Heart 92:712\u2013718","journal-title":"Heart"},{"key":"180_CR28","doi-asserted-by":"crossref","first-page":"H1332","DOI":"10.1152\/ajpheart.00715.2002","volume":"284","author":"AF Leite-Moreira","year":"2003","unstructured":"Leite-Moreira AF, Bras-Silva C, Pedrosa CA, Rocha-Sousa AA (2003) ET-1 increases distensibility of acutely loaded myocardium: a novel ETA and Na+\/H+ exchanger-mediated effect. Am J Physiol Heart Circ Physiol 284:H1332\u20131339","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"180_CR29","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/sj.bjp.0706659","volume":"147","author":"AF Leite-Moreira","year":"2006","unstructured":"Leite-Moreira AF, Castro-Chaves P, Pimentel-Nunes P, Lima-Carneiro A, Guerra MS, Soares JB, Ferreira-Martins J (2006) Angiotensin II acutely decreases myocardial stiffness: a novel AT1, PKC and Na+\/H+ exchanger-mediated effect. Br J Pharmacol 147:690\u2013697","journal-title":"Br J Pharmacol"},{"key":"180_CR30","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/sj.bjp.0706217","volume":"145","author":"J Li","year":"2005","unstructured":"Li J, Wang J, Russell FD, Molenaar P (2005) Activation of calcineurin in human failing heart ventricle by endothelin-1, angiotensin II and urotensin II. Br J Pharmacol 145:432\u2013440","journal-title":"Br J Pharmacol"},{"key":"180_CR31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/geno.1995.9996","volume":"29","author":"A Marchese","year":"1995","unstructured":"Marchese A, Heiber M, Nguyen T, Heng HH, Saldivia VR, Cheng R, Murphy PM, Tsui LC, Shi X, Gregor P, George SR, O\u2019Dwd BF, Docherty JM (1995) Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors. Genomics 29:335\u2013344","journal-title":"Genomics"},{"key":"180_CR32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.RES.0000088351.58510.21","volume":"93","author":"PB Massion","year":"2003","unstructured":"Massion PB, Feron O, Dessy C, Balligand J-L (2003) Nitric oxide and cardiac function. Ten tears after, and continuing. Circ Res 93:388\u2013398","journal-title":"Circ Res"},{"key":"180_CR33","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1097\/00004872-200112000-00011","volume":"19","author":"M Matsushita","year":"2001","unstructured":"Matsushita M, Shichiri M, Imai T, Iwashina M, Tanaka H, Takasu N, Hirata Y (2001) Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J Hypertens 19:2185\u20132190","journal-title":"J Hypertens"},{"issue":"Suppl. II","key":"180_CR34","first-page":"II","volume":"106","author":"A Morimoto","year":"2002","unstructured":"Morimoto A, Hasegawa H, Cheng H -J, Cheng C -P (2002) Urotensin II inhibits left ventricular and myocytes contractile performance and [Ca2+]i transient: normal vs CHF. Circulation 106(Suppl. II):II\u201326","journal-title":"Circulation"},{"key":"180_CR35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0014-2999(00)00672-5","volume":"406","author":"OS Opgaard","year":"2000","unstructured":"Opgaard OS, Nothacker HP, Ehlert FJ, Krause DN (2000) Human urotensin II mediates vasoconstriction via an increase in inositol phosphates. Eur J Pharmacol 406:265\u2013271","journal-title":"Eur J Pharmacol"},{"key":"180_CR36","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/01.CIR.96.4.1320","volume":"96","author":"BD Prendergast","year":"1997","unstructured":"Prendergast BD, Sagach VF, Shah AM (1997) Basal release of nitric oxide augments the Frank-Starling response in the isolated heart. Circulation 96:1320\u20131329","journal-title":"Circulation"},{"key":"180_CR37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pharmthera.2004.07.004","volume":"103","author":"FD Russell","year":"2004","unstructured":"Russell FD (2004) Emerging roles of urotensin-II in cardiovascular disease. Pharmacol Ther 103:223\u2013243","journal-title":"Pharmacol Ther"},{"key":"180_CR38","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cardiores.2004.05.009","volume":"63","author":"FD Russell","year":"2004","unstructured":"Russell FD, Molenaar P (2004) Investigation of signalling pathways that mediate the inotropic effect of urotensin-II in human heart. Cardiovasc Res 63:673\u2013681","journal-title":"Cardiovasc Res"},{"key":"180_CR39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.bjp.0703811","volume":"132","author":"FD Russell","year":"2001","unstructured":"Russell FD, Molenaar P, O\u2019Brien DM (2001) Cardiostimulant effects of urotensin-II in human heart in vitro. Br J Pharmacol 132:5\u20139","journal-title":"Br J Pharmacol"},{"key":"180_CR40","doi-asserted-by":"crossref","first-page":"H1576","DOI":"10.1152\/ajpheart.00217.2003","volume":"285","author":"FD Russell","year":"2003","unstructured":"Russell FD, Meyers D, Galbraith AJ, Bett N, Toth I, Kearns P, Molenaar P (2003) Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. Am J Physiol Heart Circ Physiol 285:H1576\u20131581","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"180_CR41","doi-asserted-by":"crossref","unstructured":"Sauzeau V, Le Mellionnec E, Bertoglio J, Scalbert E, Pacaud P, Loirand G (2001) Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ Res 88:1102\u20131104","DOI":"10.1161\/hh1101.092034"},{"key":"180_CR42","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.RES.74.5.970","volume":"74","author":"AM Shah","year":"1994","unstructured":"Shah AM, Spurgeon HA, Sollott SJ, Talo A, Lakatta EG (1994) 8-Bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes. Circ Res 74:970\u2013978","journal-title":"Circ Res"},{"key":"180_CR43","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.peptides.2005.12.007","volume":"27","author":"JB Soares","year":"2006","unstructured":"Soares JB, Rocha-Sousa A, Castro-Chaves P, Henriques-Coelho T, Leite-Moreira AF (2006) Inotropic and lusitropic effects of ghrelin and their modulation by the endocardial endothelium, NO, prostaglandins, GHS-R1a and KCa channels. Peptides 27:1616\u20131623","journal-title":"Peptides"},{"key":"180_CR44","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1152\/ajpheart.2001.280.2.H925","volume":"280","author":"A Stirrat","year":"2001","unstructured":"Stirrat A, Gallagher M, Douglas SA, Ohlstein EH, Berry C, Kirk A, Richardson M, MacLean MR (2001) Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries. Am J Physiol Heart Circ Physiol 280:925\u2013928","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"180_CR45","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1006\/bbrc.1995.1563","volume":"209","author":"M Tal","year":"1995","unstructured":"Tal M, Ammar DA, Karpuj M, Krizhanovsky V, Naim M, Thompson DA (1995) A novel putative neuropeptide receptor expressed in neural tissue, including sensory epithelia. Biochem Biophys Res Commun 209:752\u2013759","journal-title":"Biochem Biophys Res Commun"},{"key":"180_CR46","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1254\/jphs.94.376","volume":"94","author":"K Tasaki","year":"2004","unstructured":"Tasaki K, Hori M, Ozaki H, Karaki H, Wakabayashi I (2004) Mechanism of human urotensin II-induced contraction in rat aorta. J Pharmacol Sci 94:376\u2013383","journal-title":"J Pharmacol Sci"},{"key":"180_CR47","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.RES.0000084382.64418.BC","volume":"93","author":"A Tzanidis","year":"2003","unstructured":"Tzanidis A, Hannan RD, Thomas WG, Onan D, Autelitano DJ, See F, Kelly DJ, Gilbert RE, Krum H (2003) Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy. Circ Res 93:246\u2013253","journal-title":"Circ Res"},{"key":"180_CR48","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1161\/CIRCULATIONAHA.105.587519","volume":"113","author":"L Heerebeek van","year":"2006","unstructured":"van Heerebeek L, Borbely A, Niessen HW, Bronzwaer JG, van der Velden J, Stienen GJ, Linke WA, Laarman GJ, Paulus WJ (2006) Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 113:1966\u20131973","journal-title":"Circulation"},{"key":"180_CR49","doi-asserted-by":"crossref","first-page":"H348","DOI":"10.1152\/ajpheart.00512.2006","volume":"292","author":"YX Wang","year":"2007","unstructured":"Wang YX, Ding YJ, Zhu YZ, Shi Y, Yao T, Zhu YC W (2007) Role of PKC in the novel synergistic action of urotensin II and angiotensin II and in urotensin II-induced vasoconstriction. Am J Physiol Heart Circ Physiol 292:H348\u2013H359","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"180_CR50","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/hc2601.092848","volume":"104","author":"T Watanabe","year":"2001","unstructured":"Watanabe T, Pakala R, Katagiri T, Benedict CR (2001) Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation 104:16\u201318","journal-title":"Circulation"},{"key":"180_CR51","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1291\/hypres.29.375","volume":"29","author":"T Watanabe","year":"2006","unstructured":"Watanabe T, Kanome T, Miyazaki A, Katagiri T (2006) Human urotensin II as a link between hypertension and coronary artery disease. Hypertens Res 29:375\u2013387","journal-title":"Hypertens Res"},{"key":"180_CR52","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1161\/01.HYP.23.6.869","volume":"23","author":"KT Weber","year":"1994","unstructured":"Weber KT, Sun Y, Guarda E (1994) Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension 23:869\u2013877","journal-title":"Hypertension"},{"key":"180_CR53","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/hrt.2005.072280","volume":"91","author":"CP Wheeler-Jones","year":"2005","unstructured":"Wheeler-Jones CP (2005) Cell signalling in the cardiovascular system: an overview. Heart 91:1366\u20131374","journal-title":"Heart"},{"key":"180_CR54","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0008-6363(02)00341-3","volume":"55","author":"K Yamamoto","year":"2002","unstructured":"Yamamoto K, Masuyama T, Sakata Y, Nishikawa N, Mano T, Yoshida J, Miwa T, Sugawara M, Yamaguchi Y, Ookawara T, Suzuki K, Hori M (2002) Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. Cardiovasc Res 55:76\u201382","journal-title":"Cardiovasc Res"},{"key":"180_CR55","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/01.RES.0000021115.24712.99","volume":"90","author":"R Yamasaki","year":"2002","unstructured":"Yamasaki R, Wu Y, McNabb M, Greaser M, Labeit S, Granzier H (2002) Protein kinase A phosphorylates titin\u2019s cardiac-specific N2B domain and reduces passive tension in rat cardiac myocytes. Circ Res 90:1181\u20131188","journal-title":"Circ Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-007-0180-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-007-0180-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-007-0180-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:02:11Z","timestamp":1558641731000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-007-0180-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,14]]},"references-count":55,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,10,4]]}},"alternative-id":["180"],"URL":"https:\/\/doi.org\/10.1007\/s00210-007-0180-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,14]]}}}